Fund moves

Bright Minds Biosciences (DRUG)Perceptive Advisors LLC reduced its stake -24K shares

Perceptive Advisors LLC reduced its stake in Bright Minds Biosciences, per its Q2 2025 13F.

421K
Shares reported · -24K vs prior quarter: 0.41%
Disclosed portfolio weight: $11M
Reported value

Holdings as of: Jun 30, 2025
Filed: Aug 14, 2025

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Bright Minds Biosciences

For Bright Minds Biosciences, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DRUG page.

How this filing works

SEC Form 13F

Other disclosures at Bright Minds Biosciences

Everything OQRO holds on this company is on its DRUG page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO Pro Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data